Safety of fexofenadine in children treated for seasonal allergic rhinitis.

@article{Graft2001SafetyOF,
  title={Safety of fexofenadine in children treated for seasonal allergic rhinitis.},
  author={David Graft and David I. Bernstein and Alan B. Goldsobel and Eli O Meltzer and Jay Portnoy and Jian Jun Long},
  journal={Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology},
  year={2001},
  volume={87 1},
  pages={22-6}
}
BACKGROUND The incidence of allergic rhinitis in children is increasing. OBJECTIVE To evaluate the safety of fexofenadine HCI in children ages 6 through 11 years for treatment of seasonal allergic rhinitis. METHODS Two large, double-blind, randomized, placebo-controlled, parallel studies with identical protocols included patients with a positive skin test to fall allergen(s) and allergic rhinitis symptoms. Patients were randomized to receive fexofenadine 15, 30, or 60 mg or placebo twice… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2007

Use of antihistamines in pediatrics.

Journal of investigational allergology & clinical immunology • 2007

Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology • 2005
View 2 Excerpts

Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology • 2004
View 7 Excerpts

Similar Papers

Loading similar papers…